Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-20-000049
Filing Date
2020-06-09
Accepted
2020-06-09 18:12:40
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4022
  Complete submission text file 0000886744-20-000049.txt   5372
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LAWLIS V BRYAN (Reporting) CIK: 0001247681 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 20953039